ArticleFish physiology and biochemistry2026
Dietary naringenin modulates antioxidant status and hepatic lipid deposition in marine medaka (Oryzias dancena) fed a high-fat diet.
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-fat diets (HFDs) are widely used in aquaculture to improve growth and feed efficiency; however, prolonged feeding can disrupt lipid metabolism, induce oxidative stress, and impair physiological homeostasis. This study evaluated the protective effects of dietary naringenin against HFD-induced physiological alterations in the marine medaka Oryzias dancena. Fish were randomly assigned to one of four dietary treatments and fed the respective experimental diets for 45 days: a normal-fat diet (NFD, 8% crude lipid), a high-fat diet (HFD, 15% crude lipid), or an HFD supplemented with either 0.075% or 0.15% naringenin. Compared with the NFD group, HFD feeding impaired antioxidant status, altered the expression of genes associated with antioxidant defence and lipid metabolism, and promoted hepatic lipid accumulation. Dietary naringenin, particularly at 0.15%, mitigated these adverse effects by restoring muscle superoxide dismutase activity, enhancing total antioxidant capacity, reducing lipid peroxidation, partially normalizing the expression of lipid metabolism-related genes, and alleviating hepatic lipid vacuolation. These findings indicate that dietary naringenin improves antioxidant defence and helps maintain lipid metabolic homeostasis under high-fat feeding conditions, highlighting its potential as a functional dietary additive for aquaculture.
Indexed as
Identifiers
42742873What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.